Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | THRB | P10828 | 7/20 | 0.57 |
| ▸ | RARB | P10826 | 9/20 | 0.53 |
| ▸ | MEN1 | O00255 | 3/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.46 |
| ▸ | MAPT | P10636 | 3/20 | 0.46 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.46 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.46 |
| ▸ | USP2 | O75604 | 1/20 | 0.46 |
| ▸ | GAA | P10253 | 1/20 | 0.46 |
| ▸ | HPGD | P15428 | 1/20 | 0.46 |
| ▸ | RAB9A | P51151 | 1/20 | 0.46 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.46 |
| ▸ | THRA | P10827 | 5/20 | 0.44 |
| ▸ | RARA | P10276 | 2/20 | 0.43 |
| ▸ | RARG | P13631 | 1/20 | 0.43 |
| ▸ | S1PR1 | P21453 | 2/20 | 0.40 |
| ▸ | S1PR3 | Q99500 | 2/20 | 0.40 |
| ▸ | MTOR | P42345 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL75127 | 0.92 | THRB (0.57) | THRBRARBMEN1KMT2AMAPT | |
| SCHEMBL19087016 | 0.84 | RAB9A (0.53) | RARBMEN1KMT2AMAPTSMN1; SMN2 | |
| SCHEMBL76048 | 0.82 | THRB (0.67) | THRBRARBMEN1KMT2AMAPT | |
| SCHEMBL75102 | 0.82 | THRB (0.67) | THRBRARBMEN1KMT2AMAPT | |
| SCHEMBL13446673 | 0.82 | THRB (0.67) | THRBRARBMEN1KMT2AMAPT | |
| SCHEMBL815928 | 0.81 | THRB (0.69) | THRBRARBMEN1KMT2AMAPT | |
| SCHEMBL9398950 | 0.80 | MAPT (0.58) | RARBMEN1KMT2AMAPTSMN1; SMN2 | |
| SCHEMBL24599245 | 0.79 | RARB (0.57) | RARBMEN1KMT2AMAPTSMN1; SMN2 | |
| SCHEMBL101905 | 0.77 | THRB (0.89) | THRBRARBMEN1KMT2AMAPT | |
| SCHEMBL14907469 | 0.77 | THRB (0.50) | THRBRARBALDH1A1HPGDS1PR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9923148-B2 | Electroluminescent device | UDC IRELAND LIMITED (IE) | 2018-03-20 | — | — | US | disclosed |
| US-20170194568-A9 | Electroluminescent Device | UDC IRELAND LIMITED (IE) | 2017-07-06 | — | — | US | disclosed |
| US-20130079517-A1 | Electroluminescent Device | BASF SE (DE) | 2013-03-28 | — | — | US | disclosed |
| US-8012602-B2 | Blue emitting, durable, organoelectroluminescent layers containing pyrimidine moieties; full color displays; light emission efficiency and brightness | BASF SE (DE) | 2011-09-06 | — | — | US | disclosed |
| US-20100240892-A1 | ELECTROLUMINESCENT DEVICE | SCHAEFER THOMAS | 2010-09-23 | — | — | US | disclosed |
| US-20080199726-A1 | Electroluminescent Device | CIBA SPECIALTY CHEMICALS HOLDING INC. (CH) | 2008-08-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170194568-A9 | Electroluminescent Device | DPYD, PNPO, TYMP | THRB 2622/4885RARB 712/4885MEN1 1789/4885 |
| US-20080199726-A1 | Electroluminescent Device | TPMT, THPO, KYNU | THRB 1438/4885RARB 2137/4885MEN1 1856/4885 |
| US-20130079517-A1 | Electroluminescent Device | DPYD, PNPO, TYMP | THRB 2622/4885RARB 712/4885MEN1 1789/4885 |
| US-20100240892-A1 | ELECTROLUMINESCENT DEVICE | PNPO, ODC1, AXL | THRB 1300/4885RARB 361/4885MEN1 1878/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.